We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$301B
AUM Growth
+$28B
Cap. Flow
+$8.83B
Cap. Flow %
2.93%
Top 10 Hldgs %
16.6%
Holding
3,648
New
163
Increased
2,481
Reduced
676
Closed
240

Sector Composition

Rank Sector Weight
1 Technology 20.17%
2 Financials 13.07%
3 Healthcare 12.05%
4 Consumer Discretionary 10.98%
5 Industrials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VYNT
3376
DELISTED
Vyant Bio, Inc. Common Stock
VYNT
$49K ﹤0.01%
+2,609
New +$48.6K
CALA
3377
DELISTED
Calithera Biosciences, Inc
CALA
$49K ﹤0.01%
1,170
-7,284
-86% -$320K
PRPO icon
3378
Precipio
PRPO
$39.1M
$47K ﹤0.01%
+637
New +$41.8K
WATT icon
3379
Energous
WATT
$71.8M
$47K ﹤0.01%
27
HYMC icon
3380
Hycroft Mining Holding Corp
HYMC
$1.79B
$46K ﹤0.01%
1,473
AAIC
3381
DELISTED
Arlington Asset Investment Corp.
AAIC
$46K ﹤0.01%
11,092
-70,121
-86% -$284K
PTE
3382
DELISTED
PolarityTE, Inc. Common Stock
PTE
$46K ﹤0.01%
+1,767
New +$46.5K
BOXL icon
3383
Boxlight
BOXL
$1.82M
$45K ﹤0.01%
13
CATX icon
3384
Perspective Therapeutics
CATX
$327M
$45K ﹤0.01%
5,547
SMHI icon
3385
SEACOR Marine Holdings
SMHI
$209M
$45K ﹤0.01%
10,065
AVGR
3386
DELISTED
Avinger, Inc. Common Stock
AVGR
$45K ﹤0.01%
121
AREC icon
3387
American Resources Corp
AREC
$183M
$44K ﹤0.01%
+17,208
New +$52K
CNCE
3388
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$44K ﹤0.01%
10,357
-65,111
-86% -$276K
AIM
3389
AIM ImmunoTech
AIM
$6.65M
$44K ﹤0.01%
203
BCLI
3390
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$43K ﹤0.01%
752
-4,456
-86% -$238K
ENZ
3391
DELISTED
Enzo Biochem, Inc.
ENZ
$43K ﹤0.01%
13,471
-92,538
-87% -$291K
YCBD icon
3392
cbdMD
YCBD
$5.13M
$42K ﹤0.01%
40
BIOL
3393
DELISTED
Biolase, Inc.
BIOL
$42K ﹤0.01%
24
AXLA
3394
DELISTED
Axcella Health Inc. Common Stock
AXLA
$42K ﹤0.01%
412
-833
-67% -$82.6K
AGRX
3395
DELISTED
Agile Therapeutics
AGRX
$42K ﹤0.01%
16
-74
-82% -$244K
ZSAN
3396
DELISTED
Zosano Pharma Corporation
ZSAN
$41K ﹤0.01%
1,212
ALSK
3397
DELISTED
Alaska Communications Systems
ALSK
$39K ﹤0.01%
11,675
-125,875
-92% -$417K
OTIC
3398
DELISTED
Otonomy, Inc.
OTIC
$38K ﹤0.01%
16,843
SREV
3399
DELISTED
ServiceSource International, Inc.
SREV
$38K ﹤0.01%
26,733
-183,912
-87% -$242K
PHUN icon
3400
Phunware
PHUN
$42.9M
$37K ﹤0.01%
522

Similar funds

Charles Schwab's Q2 2021 Portfolio in Review

As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
  • Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
  • Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
  • Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
  • Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
  • Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
  • Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.

Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.